Gut bacteria may turn common nutrient into clot-enhancing compound
American Heart Association Rapid Access Journal Report
Embargoed until 3 p.m. CT / 4 p.m. ET Monday, April 24, 2017
DALLAS, April 24, 2017 — Gut bacteria can produce a clot-enhancing compound when people eat a nutrient found in a variety of foods including meat, eggs and milk, according to new research in the American Heart Association’s journal Circulation.
Excessive blood clotting limits or blocks blood flow which can cause heart attack, stroke, damage to the body’s organs or death.
The new study provides the first direct evidence in humans that consuming excess choline, an essential nutrient plentiful in a Western diet, raises both levels of the bacteria-produced compound, called trimethylamine N-oxide (TMAO), and the tendency of platelets to clump together and form clots. Numerous studies have shown that higher blood levels of TMAO are associated with a greater risk of heart disease, including heart attacks and strokes in humans, and recent studies showed that feeding animals choline-supplemented diets also raised their risk of clotting.
In this small study, 18 volunteers (8 vegan or vegetarian, 10 omnivores) without heart disease or major risk factors (average age 46 years, 40 percent male), took supplements of 500 milligrams (mg) of choline bitartrate twice daily for two months. The average daily intake is about 302 mg a day.
- Blood levels of TMAO rose more than 10 times after both 1 and 2 months of choline supplementation in both vegans/vegetarians and omnivores alike.
- The tendency of platelets to form clots in a laboratory test rose with choline supplementation.
- The ability of elevated TMAO levels to promote clot formation was reduced when subjects were also taking a daily baby aspirin (81 mg/day).
“Foods that raise TMAO may increase your risk for clotting and thrombotic events. Unless prescribed by your doctor, avoid supplements with choline. A Mediterranean or vegetarian diet is reported to help reduce TMAO,” said Stanley L. Hazen, M.D., Ph.D., senior author of the study, chair of Cellular and Molecular Medicine, and section head of Preventive Cardiology & Rehabilitation at the Cleveland Clinic in Ohio.
Co-authors are Weifei Zhu, Ph.D.; Zeneng Wang, Ph.D.; and W.H. Wilson Tang, M.D. Author disclosures are on the manuscript.
The National Institutes of Health and the Office of Dietary Supplements funded the study.
- After April 24, view the manuscript online.
- Digestive byproduct may predict greater risk of death among PAD patients
- Understand Your Risk for Excessive Blood Clotting
- Follow AHA/ASA news on Twitter @HeartNews
- For updates and new science from the Circulation journal follow @CircAHA
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at www.heart.org/corporatefunding.
For Media Inquiries and AHA/ASA Spokesperson Perspective: (214) 706-1173
Bridgette McNeill: (214) 706-1135; email@example.com
For Public Inquiries: (800)-AHA-USA1 (242-8721)
Life is why, science is how . . . we help people live longer, healthier lives.